D. Boral Capital Reiterates “Buy” Rating for Nano-X Imaging (NASDAQ:NNOX)

D. Boral Capital reaffirmed their buy rating on shares of Nano-X Imaging (NASDAQ:NNOXFree Report) in a report released on Friday,Benzinga reports. They currently have a $10.00 price target on the stock.

Several other equities research analysts have also issued reports on the stock. Cantor Fitzgerald lowered their target price on shares of Nano-X Imaging from $12.00 to $9.00 and set an “overweight” rating for the company in a report on Tuesday, April 1st. Alliance Global Partners reissued a “buy” rating on shares of Nano-X Imaging in a research report on Thursday, May 22nd.

View Our Latest Report on NNOX

Nano-X Imaging Price Performance

NASDAQ:NNOX opened at $5.53 on Friday. The firm has a market capitalization of $319.52 million, a price-to-earnings ratio of -6.51 and a beta of 1.99. The business has a 50 day simple moving average of $5.04 and a 200-day simple moving average of $6.28. Nano-X Imaging has a 1 year low of $3.75 and a 1 year high of $11.00.

Nano-X Imaging (NASDAQ:NNOXGet Free Report) last issued its quarterly earnings results on Thursday, May 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.02. The company had revenue of $3.00 million during the quarter, compared to the consensus estimate of $3.98 million. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. As a group, analysts expect that Nano-X Imaging will post -0.92 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nano-X Imaging

A number of large investors have recently bought and sold shares of the business. Rhumbline Advisers increased its stake in Nano-X Imaging by 6.6% in the first quarter. Rhumbline Advisers now owns 76,728 shares of the company’s stock worth $383,000 after purchasing an additional 4,756 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Nano-X Imaging by 232.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock worth $10,793,000 after purchasing an additional 1,510,806 shares during the last quarter. AQR Capital Management LLC purchased a new position in Nano-X Imaging in the 1st quarter worth about $178,000. Vident Advisory LLC purchased a new position in Nano-X Imaging in the 1st quarter worth about $55,000. Finally, Hsbc Holdings PLC lifted its holdings in Nano-X Imaging by 20.9% during the 1st quarter. Hsbc Holdings PLC now owns 47,984 shares of the company’s stock valued at $237,000 after buying an additional 8,308 shares in the last quarter. Hedge funds and other institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

(Get Free Report)

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.

Featured Articles

Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.